Combining radiotherapy and the immune system in lymphomas
Long-term follow-up results of the ZUMA-1 trial of anti-CD19 CAR T-cells for non-Hodgkin lymphoma
The future tailoring of MM treatment
The multi-cohort SCHOLAR-1 study of refractory aggressive DLBCL
The use of CAR T-cells in multiple myeloma
Adam Cohen et al.